Followers | 229 |
Posts | 14659 |
Boards Moderated | 1 |
Alias Born | 03/29/2014 |
Monday, October 08, 2018 1:34:55 AM
JAZZ pharmaceuticals, from simply a price perspective, is a stock you may want to consider looking at.
In the beginning of 2008, on February 28, 2008, Jazz Pharma's stock price was at $12.57 (very close to NWBO's high in July 2015).
http://finance.yahoo.com/q/hp?s=JAZZ&a=5&b=1&c=2007&d=5&e=14&f=2016&g=d&z=66&y=2046
Less than one year later...
by Dec 16, 2008... Jazz is laying off 24% of their work force to lower their operating expenses. That day, their stock closed at $1.30.
http://www.fiercebiotech.com/biotech/jazz-pharmaceuticals-announces-reduction-force-to-reflect-streamlined-operations
By little more than a year on April 29, 2009, the stock had reached .61¢, and had a $.052 52 week low.
http://finance.yahoo.com/q/hp?s=JAZZ&a=5&b=1&c=2007&d=5&e=14&f=2016&g=d&z=66&y=1782
https://www.forbes.com/2009/10/15/vermillion-vanda-jazz-business-healthcare-biotech.html#cc7e4927ee6c
Within a few months, it starts to rise into the single digits... then moves into the teens (in September 2010). By end 2012, it's in the $50s. By end 2013, it's reached the $100s. By the end of 2014, it had hit the $170s.
It's share price closed at $162.67 on Friday.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM